Last reviewed · How we verify

NCT03877367

Comparison of Balance Changes After Chiropractic Adjustments in Health Adults.

Completed NA Last updated 6 September 2019
What this trial tests

NA trial testing Upper extremity manipulation in Postural Balance in 23 participants. Completed in 24 July 2019.

Timeline
22 July 2019
Primary endpoint
24 July 2019
24 July 2019

Quick facts

Lead sponsorParker University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment23
Start date22 July 2019
Primary completion24 July 2019
Estimated completion24 July 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Parker University

Who can join

Adults 18 to 35, any sex, with Postural Balance or Musculoskeletal Manipulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the effect of upper and lower extremity manipulations on an upper extremity balancing task.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Immediate impact of extremity manipulation on dual task performance: a randomized, crossover clinical trial.
    Malaya CA, Haworth J, Pohlman KA, Smith DL. · · 2021 · cited 5× · PMID 33541378 · DOI 10.1186/s12998-021-00366-5
  2. Immediate Impact of Extremity Manipulation on Dual Task Performance: A Randomized, Crossover Study
    Malaya CA, Haworth J, Pohlman KA, Smith DL. · · 2020 · DOI 10.21203/rs.3.rs-78879/v1

Verify or expand the search:

Other recruiting trials for Postural Balance

Currently open trials in the same condition.

Other Parker University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03877367.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing